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ABSTRACT 
Objective: The novel molecules recovered from traditional medicinal plants have various biological applications with fewer side effects compared 
to the synthetic molecules. In this regards, the present study aimed to investigate the antibacterial, antifungal, anti-biofilm and antioxidant 
properties of novel metabolite isolated from the seeds of Citrullus colocynthis. 
Methods: The ethyl acetate (EA) extract of C. colocynthis seed was mixed with a different proportion of hexane and Silica gel column packed for the 
collection of different fractions. The active fractions were checked for its purity by thin layer chromatography and HPLC. The identified single 
molecule was further characterized using IR, 1H NMR, 13
Results: Purification of the EA extract by Silica gel column guided to identify active antimicrobial metabolite containing fractions. Further 
separation technique and spectroscopic analysis lead to confirm the novel molecule isopimpinellin with the molecular formula C
C NMR and mass spectral analysis. The minimum inhibitory concentration (MIC) of the 
compound was determined using broth microdilution method. A fungal biomass inhibition effect, the anti-biofilm and anti-oxidant property of the 
compound was evaluated. 
13H10O5
Conclusion: Novel isopimpinellin with different biological activities such as antibacterial, antifungal, antibiofilm and antioxidant properties would 
be helpful in minimizing the spreading of pathogenic microorganisms or preventing stress-related diseases. 
. The 
identified metabolite revealed promising antimicrobial activity against Bacillus subtilis (100 µg/ml) and Klebsiella pneumoniae (75 µg/ml); whereas 
Aspergillus niger and Candida albicans documented the MIC values of 150 µg/ml and 75 µg/ml respectively. Fungal biomass inhibition effect study 
further proved the antifungal activity of the compounds against the filamentous fungal strains. In addition, the compound showed promising anti-
biofilm activity against the uropathogenic strain such as Escherichia coli and Pseudomonas aeruginosa. Interestingly the antioxidant properties of the 
compound were an advantage. Both anti-biofilm and antioxidant activities were dose dependent.  
Keywords: Citrullus colocynthis, Isopimpinellin, Antibacterial, Antifungal, Antibiofilm, Antioxidant 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
From the past twenty years, many researchers are interested in the 
identification of novel bioactive metabolites with various biological 
activities. Many compounds derived from plants, bacteria, fungi and 
actinomycetes were known for its applications. Among that the 
novel unique molecules recovered from plants were highly attracted 
with researchers. Especially, the novel secondary metabolites 
derived from traditional medicinal plants have huge bioactivities 
such as anti-microbial, anti-cancer, antioxidant, antidiabetic and 
anti-inflammation. An additional factor for this renewed interest is 
the rapid rate of plant species extinction [1], which reduces the time 
left to explore the decreasing resources. Urgent efforts are necessary 
to collect and screen plants in order to determine if they should be 
conserved for the future beneficial use of humankind [2]. Medicinal 
plants are used by billions of people in most developing countries 
because of the frequently inadequate provision of modern medicine, 
their low cost, effectiveness, as well as cultural beliefs and 
preferences [3]. Treatment of infectious diseases resulted in the 
development of the excessive use of antibiotics which resulted in the 
antibiotics resistant microbial strains which increase the chance of 
treatment failure, thus necessitating the search for novel and potent 
therapeutic agents to treat bacterial and fungal infections [4-8]. 
Plants have wide amounts of metabolites that could be used to 
prevent microbial infections [9]. World Health Organization (WHO) 
estimates that more than 80 % of healthcare needs in developing 
countries are met through traditional health care practices.  
Citrullus colocynthis is one of the famous medicinal plants commonly 
available in the dessert regions of Gulf countries. It is popularly 
known as bitter apple, bitter cucumber, colocynth, and desert gourd. 
It is a perennial plant and cultivated by both vegetative and 
generative methods. Also, the plant can be cultivated by using seed 
germinations. The roots, stems, leaves, flowers, fruits, and seeds are 
widely used as medicine and as energy sources (oilseed and biofuel). 
Reports claimed that the metabolites derived from C. colocynthis 
were used for the treatment of diabetes, diabetic neuropathy, and 
hyperlipidemia [10, 11]. Cucurbitacin glycosides recovered from C. 
colocynthis were used for the treatment of breast cancer [12]. The 
novel molecules isolated from this medicinal plant is used for the 
treatment of skin diseases, leprosy, sciatica, rheumatism, sprains, 
bruises, chronic rheumatism, cutaneous diseases, chronic bronchitis, 
chest infections, ophthalmic, and secondary syphilis. Besides that, it 
is used as a good stimulant for hair growth in mammals [13]. In 
addition, the secondary metabolites such as terpenoid, alkaloids, 
phenolic compounds and other functional group containing 
molecules were used in the treatment of infectious diseases caused 
by Staphylococcus aureus, Escherichia coli, Aspergillus flavus and 
Aspergillus fumigates [14]. The present study aimed to isolate novel 
molecule from this plant and investigates its antibacterial, antifungal 
properties. The novel molecule recovered from this medicinal plant 
exerted significant, antimicrobial, anti-biofilm and antioxidant 
activity; which give special attention to the pharmaceutical 
companies for the application of this molecules towards the 
treatment of degenerative disorders and cardiovascular diseases. 
MATERIALS AND METHODS  
Collection of plant materials and extraction 
The seeds of C. colocynthis were collected from the Jazan Mountain 
(Al-Sarawat) of Saudi Arabia in March 2014. Jazan Region is the 
second smallest region of Saudi Arabia. It stretches some 300 km 
along the southern Red Sea coast, just north of Yemen. It covers an 
area of 11,671 km². The Al-Sarawat Mountains inland, which rise to 
about 3,000, meters This mountain region. The seeds were 
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botanically confirmed and authenticated in the Department of 
Botany and Microbiology, King Saud University, Riyadh, Saudi 
Arabia. The seeds were stored in the seed collection unit with the 
voucher CS-15-24. Approximately 500 gram of the seeds was 
washed thoroughly with common drinking water and air dried to 
remove the moisture content. Further, the seeds were kept for shade 
dry for 7 d. After that, the clean seeds were powdered in a mixer, 
and the fine powders were transferred into 2 l flask containing 1.5 l 
of ethyl acetate. The mixture was kept in orbital shaker for 48 h at 
room temperature with airtight cotton on the mouth part of the 
flask. After that, the debris free supernatant was separated by 
centrifugation at 10000 rpm for 20 min. The collected debris free 
supernatant was concentrated using vacuum evaporator at room 
temperature, and the crude extract was stored in the light resistant 
brown bottle for further laboratory usages.  
Screening of the crude extract and identification of active 
molecules 
The antibacterial and antifungal activity of the collected extract was 
investigated by disc diffusion method [15]. Since the extract 
exhibited comparatively better antimicrobial activity; it has been 
purified using column chromatography. Silica gel (Acme’s 100–200 
mesh) was packed using hexane solvent, and the crude extract was 
mixed with silica gel with the ratio of 1:3 and carefully transferred 
on the top of the column. Later, the elution was carried out by using 
a different ratio of solvents such as hexane, ethyl acetate, and 
methanol. The collected fractions were pooled together based on 
their R f  values and the shortlist fractions (7 no) were vacuum 
evaporated. The concentrated fractions were further checked for 
their antimicrobial activity using disc diffusion method. The fraction 
7 showed comparatively better activity was further purified using 
small level column packed with silica gel. After that, the packed 
fraction was carefully eluted by pouring different ratio of ethyl 
acetate and methanol. The collected fractions were pooled together 
based on their TLC profile and evaporated and checked for its 
antimicrobial activity. The TLC profile showing single spot was 
further studied for the chemical characterization. The functional 
group of the molecule was identified using Infrared spectroscopy 
(IR) by KBr pellet method. 1H NMR was run at either 300 or 400MHz 
and 13
Antimicrobial activity 
C NMR at 75 MHz using the solvent signal as a reference. The 
MASS spectrum of the molecules was determined using an 
electrospray ionization tandem mass spectrometry (ESI-MS/MS). 
The separation was carried out on an ODS-H column (100 × 2.1 mm 
i.d. 3.5 µm particle size; Shiseido, Tokyo, Japan) at a flow rate of 0.2 
mL/min. The ion source was set to run in the negative ion mode (-
3.5 kV) with N2 sheath gas at a nebulising pressure of 50 psi (344 
kPa). The capillary temperature and voltage were set at 365oC and-
15 V, respectively. The ion trap MS analysis was carried out with N2 
as the collision gas, and the normalized collision energy was set to 
30 %. The total ion chromatogram was obtained from 150 to 2000 
m/z. The LC solvent system was delivered at a rate of 1.0 ml/min 
and consisted of a mixture of (A) 30 mM acetic acid: 0.07 % formic 
acid: methanol (85:5:10, v/v/v) and (B) 25 mM acetic acid: 0.05 % 
formic acid: methanol (72:5:23, v/v/v). 
Tested microorganisms 
The following bacteria and fungi were used for the experiment. 
Bacteria: Bacillus subtilis (ATCC 6059), Enterococcus faecalis (ATCC 
29212), Staphylococcus aureus (ATCC 6538), Staphylococcus 
epidermidis (ATCC 1228), Escherichia coli (ATCC 11229), Klebsiella 
pneumoniae (ATCC 15380) and Pseudomonas aeruginosa (ATCC 
27853); Fungi: Aspergillus flavus, Aspergillus niger, Alternaria 
alternata, Curvularia maculans, Curvularia lunata, Epidermophyton 
floccosum, Fusarium oxysporum, Penicillium citrinum, Botyritis 
cinerea and Candida albicans. The studied microbial pathogens were 
procured from American Type Culture Collection (ATCC).  
Preparation of inoculums 
Bacterial inoculums were prepared by growing cells in Mueller 
Hinton Broth (Himedia) for 24 h at 37 oC. These cell suspensions 
were diluted with sterile MHB to provide initial cell counts of about 
104 CFU/ml. The filamentous fungi were grown on sabouraud 
dextrose agar (SDA) slants at 28 oC for 10 d and the spores were 
collected using sterile doubled distilled water and homogenized. Yeast 
was grown on sabouraud dextrose broth (SDB) at 28 o
Minimum inhibitory concentration (MIC) 
C for 48 h.  
The minimum inhibitory concentration was performed according to 
the standard reference method [16]. The molecule was dissolved in 
water together with 2 % dimethyl sulfoxide (DMSO). The initial 
concentration of compound was 1 mg/ml. The initial test 
concentration was serially diluted twofold. Each well was inoculated 
with 5 µl of a suspension containing 108 CFU/ml of bacteria and 104 
spores/ml of fungi, respectively. For fungi, the plates were incubated 
for 24, 48 or 72 h at 28 oC while bacteria plates were incubated for 
24 h at 37 o
Anti-biofilm activity 
C. MIC was defined as the lowest extract concentration, 
showing no visible fungal growth after incubation time. 5 µl of tested 
broth was placed on the sterile MHA plates for bacteria and 
incubated at respective temperature. The MIC for bacteria was 
determined as the lowest concentration of the compound inhibiting 
the visual growth of the test cultures on the agar plates. 
The anti biofilm activity was evaluated by following the method of 
Rejiniemon et al. [15]. E. coli and P. aeruginosa were cultivated in 
nutrient broth at 37 °C for 48 h under static condition. After that, the 
cultivated sterile tubes were washed thoroughly with sterile 
distilled water and stained with of 0.1 % (v/v) Crystal violet and 
Safranin for 10 min. The excess stain was removed by washing with 
sterile water. Tubes were then dried for overnight at 37 °C. Crystal 
violet-stained adherent S. aureus bacteria were re-dissolved in 
dimethyl sulphoxide (DMSO) whereas safranin-stained adherent P. 
aeruginosa bacteria were re-dissolved in 30 % (v/v) glacial acetic 
acid. Thereafter, absorbance was recorded at 570 nm for crystal 
violet stained DMSO suspension and at 492 nm for Safranin stained 
glacial acetic acid suspension. Each test was performed in triplicate. 
In vitro antioxidant activity  
The antioxidant property of the isolated molecule was determined 
using DPPH method [17]. Briefly, freshly prepared DPPH solution in 
an ice cold methaol (0.15 %) was mixed with different 
concentrations of (10–50 µg/ml) of the compound under dark 
environment for 30 min, and the absorbance was read at 515 nm. 
The antioxidant activity was expressed as IC50
Scavenging activity (%) = [1-(absorbance of sample-absorbance of 
blank)/absorbance of control] Χ 100 
 (µg/ml) (the 
antiradical dose required to cause a 50 % inhibition). Vitamin C was 
used as standard. The ability to scavenge the DPPH radical was 
calculated by the following formula:  
RESULTS 
Citrullus colocynthis is commonly used in the treatment of various 
health related diseases and infectious disorders. In gulf region, this 
medicinal plant is very rarely studied for their bioactivities against 
various microbial pathogens. Therefore, the present study aimed to 
investigate the antibacterial, antifungal, anti biofilm and antioxidant 
properties of novel metabolite recovered from this medicinal plant. 
The seeds were collected from the gulf region were powdered and 
mixed with ethyl acetate solvent for the extraction. Initial 
antibacterial and antifungal studies of the extract revealed that the 
extract was prominent for further purification by collection of 
various fractions. Therefore, extract was packed in the column for 
further purification and the selected seven fractions were quickly 
screened against the selected microbial pathogens. The suspected 
fraction was checked for its purity in the thin layer chromatography 
and further confirmed by HPLC. The identified single molecule was 
further characterized for its chemical structure and molecular 
formula identification. The molecular weight of the compounds was 
determined using ESI-MS/MS. MS analysis indicated that the 
compound revealed major fragmentation at 245 (fig. 1). 1H NMR and 
13C NMR chemical analysis exhibit the band and signal at 1.1, 1.5, and 
2.9 (1H NMR) and 13C NMR showed the peaks and signals at 21.3, 28, 
45, 56, 60.7, 99.8, 110.3, 115, and 125 respectively. The functional 
group of the metabolite study indicated the absorption maximum 
band at 910 and 812 places confirmed the presence of the hydroxyl 
double bond. Based on the above spectral results, it is predicted that 
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the metabolite also containing phenolic groups, hydroxyl double 
bonds in their chemical structure. Further, the chemical structure of 
the compound was drawn as C13H10O5
 
 and named as isopimpinellin 
(fig. 2). 
 
Fig. 1: The Mass spectrum of the isolated compound isolated from C. colocynthis 
 
 
Fig. 2: The chemical structure of the compound isolated from C. 
colocynthis 
 
Antibacterial activity of the compound 
The antibacterial potentials of the isolated compounds against the 
Gram-positive and Gram-negative microbial pathogens were 
investigated by measuring the minimum inhibitory concentrations 
by broth microdilution method. Among the Gram-positive bacteria, 
S. aureus exhibited the MIC of 50 ug/ml followed by B. subtilis and S. 
epidermidis (100 ug/ml). Whereas, E. faecalis revealed the highest 
MIC values (200 ug/ml) (fig. 3). In the case of Gram-negative 
bacteria, E. coli, K. pneumoniae and P. aeroginosa documented the 
MIC values of 50, 75 and 75 ug/ml respectively (table 1). The MIC 
values of the standard antibiotic were ranged from 2.5 to 50 ug/ml 
respectively for the tested microbial pathogens. 
 
 
Fig. 3: In vitro antibacterial and antifungal activity of the 
compound against Staphylococcus epidermidis
 
Table 1: Minimum inhibitory concentration of the compound against Gram positive and Gram negative bacteria 
Pathogenic strains Minimum inhibitory concentration (MIC) (µg/ml) 
Compound Streptomycin sulfate 
Gram-positive     
Bacillus subtilis (ATCC 6059) 100 2.5 
Staphylococcus aureus (ATCC 6538) 50 37.5 
Staphylococcus epidermidis (ATCC 1228) 100 10 
Enterococcus faecalis (ATCC 29212) 200 25 
Gram-negative     
Escherichia coli (ATCC 11229)  50 25 
Klebsiella pneumoniae (ATCC 15380) 75 25 
Pseudomonas aeroginosa (ATCC 27853) 75 50 
ATCC, American type culture collection; Streptomycin, (standard antibacterial agents). The experiments were performed in three times for the 
confirmation of the results 
 
Antifungal activity of the compound 
Table 2 represented the MIC values of the isolated compounds 
towards fungal pathogens. Among the ten tested pathogens, F. 
oxysporum and C. albicans shared MIC values of 75 ug/ml and A. flavus, 
C. maculans, E. floccosum and P. citrinum displayed MIC values of 100 
ug/ml respectively. A. alternate and B. cinerea documented the highest 
MIC values (200 ug/ml). C. lunata and A. niger shared MIC values of 
125 and 150 ug/ml respectively.  
Standard antifungal metabolite revealed MIC values ranging within 
25–100 µg/ml, respectively. 
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Table 2: Minimum inhibitory concentration of the compound against fungi 
Pathogenic strains Minimum inhibitory concentration (MIC) (µg mL-1) 
Compound Standard 
Aspergillus flavus 100 50 
Aspergillus niger  150 25 
Alternaria alternata 200 50 
Botyritis cinerea  200 50 
Candida albicans 75 25 
Curvularia maculans 100 50 
Curvularia lunata 125 100 
Epidermophyton floccosum 100 50 
Fusarium oxysporum 75 25 
Penicillium citrinum 100 25 
The MIC of the compound was determined by broth microdilution method. The experiments were performed in three times for the confirmation of 
the results. 
 
Growth inhibition effect of the compound against fungal pathogens 
The growth inhibition effects of the compounds against the fungal 
pathogen were tested by supplementing 100 mg of the compounds 
in 100 ml of SD broth. After incubating the flasks for three days at 30 
°C, the dry weight measurement of the fungal cells confirmed that 
the compounds significantly inhibited the growth when compared to 
the dry cell weight of the control fungal pathogens. Through analysis 
of the results indicated that the compounds revealed 62.2 % of the 
growth of Penicillium citrinum, whereas, F. oxysporum, C. lunata, C. 
maculans and A. flavus shared 53.46, 55.30, 52.63, 54.34 and 55.33 
% of the growth inhibition (fig. 4). Among the fungi, E. floccosum, 
documented 43 % of biomass inhibition effect when the compound 























Fig. 4: Fungal biomass inhibition effect of the compound 
determined by dry cell weight 
 
Anti-biofilm property of the compound 
In vitro anti-biofilm property of the isolated compound was showed 
in fig. 5. The anti-biofilm of the compounds against E. coli and P. 
aeruginosa indicated that the activity was concentration dependent. 
The highest property was achieved in P. aeruginosa at 100 ug/ml, 
and the novel compound showed activity against all the tested 























Fig. 5: In-vitro anti-biofilm activity of the compound isolated 
from C. colocynthis 
Antioxidant activity of the compound 
In vitro antioxidant activity of the isolated compound was 
determined by measuring the DPPH scavenging assays. Results 
indicated that the antioxidant potentials of the compound were 
concentration dependent, and the results were directly proportional 
to the tested concentrations fig. 6. The results concluded that the 
isolated compound had the highest hydroxyl radical scavenging 
ability, with an inhibition rate of 83.5 % at 500 µg/ml concentration, 




Fig. 6: In-vitro antioxidant property of the compound isolated 
from C. colocynthis 
 
DISCUSSION 
It is understood that the importance of identification of novel 
molecules from traditionally used medicinal plants for the treatment 
of various biological disorders in humans have higher advantages 
over the synthetic molecules because of the tremendous 
disadvantages such as side effects, creates allergic reactions, 
immune suppression, hypersensitivity, and the generation of 
multiple drugs resistant microbial strains. Therefore, it would be 
better if the researchers and scientist concentrate deeply in the field 
of traditional medicinal plants for the identification of novel 
bioactive molecules for various diseases [18]. The application of 
medicinal plants for the treatment of various disorders have been 
used for many years, and modern world populations still depend on 
the usage of traditional medicinal plants. The identified molecules 
from medicinal plants were the active ingredients in commonly used 
antibiotics [19]. Medicinal plants available in the man free 
environment is the ideal place for the discovery of novel molecules 
with various biological activities such as antibacterial, anticancer, 
antifungal, antidiarrheal, analgesics, antidiabetic, anti-inflammatory 
and antioxidant agents as well as various therapeutic potentials [20]. 
The importance’s of medicinal plants in Gulf region are widely 
studied by few researchers. However, the in-depth identification and 
characterization of important medicinal plants were very rarely 
studied. Citrullus colocynthis is one among the medicinal plant. 
Citrullus colocynthis is used for the treatment of various diseases 
such as cancer and skin infections. However, the importance of 
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towards the inhibition of microbial pathogens such as bacteria and 
filamentous fungi were rarely studied. Therefore, the organic extracts 
of this plant seeds were studied for its antimicrobial activity. Initial 
screening revealed promising activity against the tested microbial 
pathogens. Further, the purification studies and chemical 
characterization of the selected fraction confirmed as isopimpinellin. 
Antibacterial and antifungal potentials of the identified compounds 
were determined by evaluating its minimum inhibitory 
concentration. The results indicated that the identified molecules 
showed active in Gram-positive than the Gram-negative bacteria. 
The MIC values of the compound towards E. coli are interesting 
because it release various toxins like compounds in the intestine and 
affect the intestinal wall [21]. The MIC values were ranged from 50-
200 ug/ml for both bacterial and fungal pathogens. Also, the results 
obtained in the present study were very significant. Interestingly the 
activities of the identified molecules towards the fungal pathogens 
were highly attractive, because, among the studied fungal strains, 
Aspergillus species were the causative agents for the cirrhosis of the 
liver. Gurudeeban et al. (2010) reported that the antimicrobial 
properties of C. colocynthis due to the presence of phtochemicals 
such as saponins, alkaloids, cardiac glycosides, steroids and tannins 
[22]. The identified novel compounds exerted remarkable fungal 
biomass inhibition against the pathogenic filamentous fungi. The 
complete or partial suppression of the growth of the fungal species 
in the liquid culture medium is an advantage of these isolated 
compounds. The results obtained were coincides with the recent 
report oAl-Dhabi et al. (2015), where the novel iso steviol recovered 
from endangered medicinal plant Pittosporum revealed fungal 
biomass inhibition against the filamentous fungi such as F. 
oxysporum, P. chrysogenum, B. cinerea, A. oryzae, A. clavatus and E. 
floccosum respectively [24]. 
Interestingly, the identified compound excels antibiofilm activity 
against the pathogens such as E. coli and P. aeroginosa. It is 
predicted that the compound might have interacted with E. coli 
and P. aeroginosa by preventing their attachment on the surfaces 
and the epithelial mucosa [23]. Among the tested pathogenic strains, 
P. aeruginosa is the most dangerous Gram-negative strain with high 
resistance to commonly used antibiotics [25]. The results of this 
study evidenced that the active compounds might have created the 
negative environmental conditions to the microbes by attaching on 
the surfaces; this is because the compounds might have a direct 
effect on the extracellular membranes of the strains which contain 
lipopolysaccharides and fimbriae [26]. 
In addition, the identified compound exhibited significant 
antioxidant activities. Even though the antioxidant activities were 
does dependent, at higher concentration, the compound 
comparatively revealed similar activity to the standard compound. 
Kamlesh et al. (2007) claimed that the microbial infections caused 
by the pathogenic strains create the environment for the generation 
of reactive molecules from oxygen which cause severe damage to the 
cells [27]. Matsui et al. (2007) reported that the presence of free 
radicals in the human body creates unfavorable conditions for 
membrane fluidity and enzyme receptor further causes diseases 
related to like diabetes, rheumatoid arthritis, cancer, aging, 
cardiovascular disease and epilepsy [28]. Traditional plant 
molecules contain phenolic functional groups in their structure have 
been proved for antioxidant activity [29]. Similar to the other plant 
molecule, the identified novel compound documented significant 
antioxidant activity [30]. 
CONCLUSION 
In summary, we have described the antibacterial, antifungal, 
antibiofilm and antioxidant properties of the novel compound 
identified from Citrullus colocynthi. The MIC values of the compound 
against the studied pathogens were ranged from 75-200 ug/ml 
respectively. Among the bacterial strains, Gram-positive bacteria 
were more prominent in their activity, and filamentous fungal 
strains also showed good activity. Fungal biomass inhibition studies 
proved that the identified compounds have real activity. Besides the 
antimicrobial activities, the compound exhibited anti-biofilm activity 
against E. coli and P. aeroginosa. Interestingly, the identified 
compound documented good antioxidant activity; therefore, this 
compound could also be useful for the treatment of degenerative 
disorders and cardiovascular diseases. Identification, 
characterization and biological importance of the metabolite 
isolated from these medicinal plants give further attraction to the 
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